256 related articles for article (PubMed ID: 33005486)
1. Genomic diversity and evolution, diagnosis, prevention, and therapeutics of the pandemic COVID-19 disease.
Hoque MN; Chaudhury A; Akanda MAM; Hossain MA; Islam MT
PeerJ; 2020; 8():e9689. PubMed ID: 33005486
[TBL] [Abstract][Full Text] [Related]
2. Tripartite Combination of Candidate Pandemic Mitigation Agents: Vitamin D, Quercetin, and Estradiol Manifest Properties of Medicinal Agents for Targeted Mitigation of the COVID-19 Pandemic Defined by Genomics-Guided Tracing of SARS-CoV-2 Targets in Human Cells.
Glinsky GV
Biomedicines; 2020 May; 8(5):. PubMed ID: 32455629
[TBL] [Abstract][Full Text] [Related]
3. Current coronavirus (SARS-CoV-2) epidemiological, diagnostic and therapeutic approaches: An updated review until June 2020.
Nabil A; Uto K; Elshemy MM; Soliman R; Hassan AA; Ebara M; Shiha G
EXCLI J; 2020; 19():992-1016. PubMed ID: 32788913
[TBL] [Abstract][Full Text] [Related]
4. CoronaVR: A Computational Resource and Analysis of Epitopes and Therapeutics for Severe Acute Respiratory Syndrome Coronavirus-2.
Gupta AK; Khan MS; Choudhury S; Mukhopadhyay A; Sakshi ; Rastogi A; Thakur A; Kumari P; Kaur M; Shalu ; Saini C; Sapehia V; Barkha ; Patel PK; Bhamare KT; Kumar M
Front Microbiol; 2020; 11():1858. PubMed ID: 32849449
[TBL] [Abstract][Full Text] [Related]
5. The COVID-19 Pandemic: A Comprehensive Review of Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and Control.
Helmy YA; Fawzy M; Elaswad A; Sobieh A; Kenney SP; Shehata AA
J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32344679
[TBL] [Abstract][Full Text] [Related]
6. Laboratory Testing Methods for Novel Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2).
D'Cruz RJ; Currier AW; Sampson VB
Front Cell Dev Biol; 2020; 8():468. PubMed ID: 32582718
[TBL] [Abstract][Full Text] [Related]
7. A contemporary insight of metabolomics approach for COVID-19: Potential for novel therapeutic and diagnostic targets.
Asim M; Sathian B; Banerjee I; Robinson J
Nepal J Epidemiol; 2020 Dec; 10(4):923-927. PubMed ID: 33495710
[TBL] [Abstract][Full Text] [Related]
8. Genomic Epidemiology and Recent Update on Nucleic Acid-Based Diagnostics for COVID-19.
Rabaan AA; Al-Ahmed SH; Sah R; Al-Tawfiq JA; Haque S; Harapan H; Arteaga-Livias K; Aldana DKB; Kumar P; Dhama K; Rodriguez-Morales AJ
Curr Trop Med Rep; 2020; 7(4):113-119. PubMed ID: 32989413
[TBL] [Abstract][Full Text] [Related]
9. Can CRISPR/Cas Technology Be a Felicitous Stratagem Against the COVID-19 Fiasco? Prospects and Hitches.
Konwarh R
Front Mol Biosci; 2020; 7():557377. PubMed ID: 33134311
[TBL] [Abstract][Full Text] [Related]
10. A novel statistical method predicts mutability of the genomic segments of the SARS-CoV-2 virus.
Darooneh AH; Przedborski M; Kohandel M
QRB Discov; 2022; 3():e1. PubMed ID: 35106478
[TBL] [Abstract][Full Text] [Related]
11. Recent updates in COVID-19 with emphasis on inhalation therapeutics: Nanostructured and targeting systems.
Abdellatif AAH; Tawfeek HM; Abdelfattah A; El-Saber Batiha G; Hetta HF
J Drug Deliv Sci Technol; 2021 Jun; 63():102435. PubMed ID: 33643448
[TBL] [Abstract][Full Text] [Related]
12. Covid-19 Study, Diagnostic and Therapeutic Transition.
Lu DY; Lu TR
Recent Adv Antiinfect Drug Discov; 2023 Mar; ():. PubMed ID: 36999700
[TBL] [Abstract][Full Text] [Related]
13. Time-series analyses of directional sequence changes in SARS-CoV-2 genomes and an efficient search method for candidates for advantageous mutations for growth in human cells.
Wada K; Wada Y; Ikemura T
Gene X; 2020 Dec; 5():100038. PubMed ID: 32835214
[TBL] [Abstract][Full Text] [Related]
14. Potential Trends of Point-of-Care Diagnostics-The Next Generation of the Laboratory Diagnosis.
Lin SW; Shen CF; Cheng CM
Diagnostics (Basel); 2020 Sep; 10(10):. PubMed ID: 33007954
[TBL] [Abstract][Full Text] [Related]
15. Genetics and genomics of SARS-CoV-2: A review of the literature with the special focus on genetic diversity and SARS-CoV-2 genome detection.
Rahimi A; Mirzazadeh A; Tavakolpour S
Genomics; 2021 Jan; 113(1 Pt 2):1221-1232. PubMed ID: 33007398
[TBL] [Abstract][Full Text] [Related]
16. Comparison of influenza type A and B with COVID-19: A global systematic review and meta-analysis on clinical, laboratory and radiographic findings.
Pormohammad A; Ghorbani S; Khatami A; Razizadeh MH; Alborzi E; Zarei M; Idrovo JP; Turner RJ
Rev Med Virol; 2021 May; 31(3):e2179. PubMed ID: 33035373
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Genomic Characteristics and Transmission Routes of Patients With Confirmed SARS-CoV-2 in Southern California During the Early Stage of the US COVID-19 Pandemic.
Zhang W; Govindavari JP; Davis BD; Chen SS; Kim JT; Song J; Lopategui J; Plummer JT; Vail E
JAMA Netw Open; 2020 Oct; 3(10):e2024191. PubMed ID: 33026453
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in the nucleic acid-based diagnostic tool for coronavirus.
Prabhakar PK; Lakhanpal J
Mol Biol Rep; 2020 Nov; 47(11):9033-9041. PubMed ID: 33025503
[TBL] [Abstract][Full Text] [Related]
19. Zoonotic evolution and implications of microbiome in viral transmission and infection.
Rajeev R; Prathiviraj R; Kiran GS; Selvin J
Virus Res; 2020 Dec; 290():198175. PubMed ID: 33007342
[TBL] [Abstract][Full Text] [Related]
20. A Novel Strategy for the Development of Vaccines for SARS-CoV-2 (COVID-19) and Other Viruses Using AI and Viral Shell Disorder.
Goh GK; Dunker AK; Foster JA; Uversky VN
J Proteome Res; 2020 Nov; 19(11):4355-4363. PubMed ID: 33006287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
